Elsevier launches EPIDEMICS – The journal on infectious disease dynamics
A new integrating platform for an emerging field
Amsterdam, 27 April 2009 – Elsevier, the world-leading publisher of scientific, technical and medical information products and services, is pleased to announce the launch of a new journal, entitled Epidemics - the journal on infectious disease dynamics.
This peer-reviewed journal will publish papers on infectious disease dynamics in the broadest sense. Its scope covers both within-host dynamics of infectious agents, and dynamics at the population level, and particularly the interaction between the two. Authors are invited to submit their work to Epidemics through the online submission and review system.
“The growth of research in infectious disease dynamics is reflected in the large number of quality papers that have been published in a wide range of discipline-specific and disease-specific journals, as well as the high impact generalist science publications”, as stated in their editorial by the Editors, Sebastian Bonheoffer from Switzerland, Neil Ferguson from the UK, Hans Heesterbeek from the Netherlands, and Bette Korber from the USA. “There is a lack of a single publication dedicated to infectious disease dynamics research which brings together the disciplines contributing to the field. “With Epidemics we aim to address this need, and thereby play some part in helping this research field come of age”.
“I am delighted and proud to see that so many of the leaders of the field have already contributed to the first issue of Epidemics”, said Floris de Hon, Elsevier’s Executive Publisher ‘Immunology & Microbiology’, “It is a highly valuable and very timely publication and I am convinced that it will become well-read across the world”. He added: “Together with the related annual congress on Epidemics, launched last year, we aim to provide an integrated platform for research on infectious disease dynamics, an emerging field in the study of infectious diseases”.
###
Notes to editors:
To receive a copy of Epidemics Volume 1, Issue 1, 2009, please contact the press office at newsroom@elsevier.com. The first issue of Epidemics is also available for free at http://www.sciencedirect.com/science/journal/17554365.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Media Contact:
Floris de Hon
Elsevier
+31 20 485 2498
f.hon@elsevier.com
